Cut-off | Sensitivity (95%CI) | Specificity (95%CI) | PPV (95%CI) | NPV (95%CI) |
---|---|---|---|---|
Part A: ICU mortality | ||||
 | Derivation cohort | |||
0% PCT decrease | 0.24 (0.13-0.40) | 0.89 (0.82-0.94) | 0.48 (0.27-0.69) | 0.74 (0.66-0.81) |
40% PCT decrease | 0.44 (0.30-0.60) | 0.82 (0.73-0.88) | 0.50 (0.34-0.66) | 0.78 (0.69-0.85) |
60% PCT decrease | 0.60 (0.44-0.74) | 0.67 (0.57-0.76) | 0.43 (0.30-0.56) | 0.80 (0.71-0.88) |
80% PCT decrease | 0.91 (0.79-0.98) | 0.35 (0.26-0.45) | 0.37 (0.28-0.46) | 0.90 (0.77-0.97) |
 | Validation cohort | |||
0% PCT decrease | 0.50 (0.26-0.74) | 0.81 (0.71-0.89) | 0.36 (0.18-0.57) | 0.88 (0.79-0.95) |
40% PCT decrease | 0.67 (0.41-0.87) | 0.68 (0.57-0.78) | 0.31 (0.17-0.48) | 0.90 (0.80-0.96) |
60% PCT decrease | 0.78 (0.52-0.94) | 0.61 (0.49-0.71) | 0.30 (0.17-0.45) | 0.93 (0.82-0.98) |
80% PCT decrease | 0.83 (0.59-0.96) | 0.37 (0.27-0.48) | 0.22 (0.13-0.34) | 0.91 (0.76-0.98) |
Part B: In-hospital mortality | ||||
 | Derivation cohort | |||
0% PCT decrease | 0.22 (0.12-0.37) | 0.89 (0.81-0.94) | 0.48 (0.27-0.69) | 0.71 (0.62-0.79) |
40% PCT decrease | 0.41 (0.27-0.56) | 0.81 (0.72-0.88) | 0.50 (0.34-0.66) | 0.75 (0.66-0.82) |
60% PCT decrease | 0.59 (0.44-0.73) | 0.68 (0.58-0.76) | 0.46 (0.33-0.59) | 0.78 (0.68-0.86) |
80% PCT decrease | 0.92 (0.80-0.98) | 0.36 (0.27-0.46) | 0.40 (0.31-0.50) | 0.90 (0.77-0.97) |
 | Validation cohort | |||
0% PCT decrease | 0.43 (0.25-0.63) | 0.83 (0.73-0.91) | 0.52 (0.31-0.72) | 0.78 (0.67-0.87) |
40% PCT decrease | 0.63 (0.44-0.80) | 0.72 (0.60-0.82) | 0.49 (0.32-0.65) | 0.83 (0.71-0.91) |
60% PCT decrease | 0.70 (0.51-0.85) | 0.64 (0.52-0.75) | 0.45 (0.30-0.60) | 0.84 (0.71-0.92) |
80% PCT decrease | 0.77 (0.58-0.90) | 0.38 (0.26-0.50) | 0.34 (0.23-0.46) | 0.79 (0.62-0.91) |